Lecture # 25 November 13, 2024 at 10:30 AM
Definition and Relevance
Asthma is a chronic obstructive respiratory disease affecting the airways.
It involves inflammation, bronchoconstriction, and mucus plug formation, primarily affecting the upper airways (bronchi and upper bronchioles).
Triggers include allergens like pollen, dust mites, animal dander, smoke, infections, and cold air
Key Features of Asthma
In asthmatic airways:
Inflammation: Swelling of the airway lining.
Bronchoconstriction: Tightening of the smooth muscles around the airway.
Mucus plugs: Excessive secretion blocks airflow.
Risk Factors: Things that increase the chance of getting asthma.
IgE Sensitivity: How the body reacts with a type of antibody called immunoglobulin E when exposed to allergens.
Genetic Factors: The role of family history in developing asthma.
Environmental Triggers: Factors in our surroundings that can provoke asthma attacks, such as temperature changes, smoke, dust, and infections.
Understanding Asthma Pathophysiology
Airway Differences
Normal vs. Asthmatic Airways:
Normal Airways: Are wide and allow air to flow easily with very little mucus.
Asthmatic Airways: Have some issues like:
Mucus Plugs: Thick mucus that can block air passages.
Inflammation: Swelling in the airways that makes it harder to breathe.
Bronchoconstriction: Tightening of the muscles around the airways, making them narrow.
Cellular Involvement
Key Cell Types in Asthma:
Goblet Cells: Produce mucus that can help trap particles and germs.
Mast Cells: Release chemicals like histamine that can cause allergy symptoms when activated.
Leukocytes: White blood cells that help fight infections and inflammation.
Immunological Response
IgE Sensitivity: This reaction happens when the body encounters allergens like pollen or dust mites.
Degranulation Process: When mast cells release histamine, it can lead to:
Contraction of bronchial smooth muscle (causing narrowing of the airways).
Increased inflammation (leading to symptoms like coughing and wheezing).
Histamine, a key granule content, is released into the extracellular fluid.
Mechanism of Action
Histamine and Receptors
H1 Receptor Activation: When histamine binds to H1 receptors, it causes:
Contraction of bronchial smooth muscle.
Release of other inflammatory substances.
Inflammation:
Histamine binds to H1 receptors on leukocytes.
Activates phospholipase A2 enzyme, which breaks down phospholipids into arachidonic acid.
Arachidonic acid is converted into leukotrienes, pro-inflammatory molecules that:
Increase swelling.
Stimulate goblet cells to secrete more mucus.
Role of Epinephrine
Epinephrine Functions: This hormone helps by:
Binding to beta-2 receptors on both mast cells and bronchial muscles.
Increasing levels of cyclic AMP, which leads to:
Inhibition of mast cell degranulation.
Relaxation of smooth muscle, helping to open the airways.
Pharmacological Interventions
Common Medications for Asthma
Types of Asthma Medications
Long-Term Anti-Inflammatory Drugs
Prednisone:
A steroid taken as a puffer for weeks.
Inhibits transcription of phospholipase A2, reducing leukotriene production.
Used for sustained inflammation control.
Short-Term Bronchodilators
Salbutamol (Ventolin):
A beta-2 receptor agonist, similar to epinephrine but with a longer half-life.
Delivered via puffer for immediate relief of bronchoconstriction.
Promotes smooth muscle relaxation and airway dilation.
Cromolyn Sodium: Works by preventing mast cells from releasing histamine.
Drugs for Asthma Management
Goals of Treatment
Inhibit inflammation.
Promote bronchodilation.
Inhibit degranulation.
Limitations of Antihistamines
Antihistamines can help in the short term but may cause side effects like tiredness and dry mouth. They are not a good long-term solution for asthma.
Exercise-Induced Bronchoconstriction (EIB)
Prevalence and Timing
EIB is common in many people with asthma (about 50-90%) and also in some without asthma (around 10%).
Some individuals experience airway narrowing during or after exercise, requiring additional management
Symptoms usually show up after exercise, not during.
Factors Influencing EIB
Exercise Intensity: The chance of EIB increases with higher intensity exercise.
Type and Duration of Exercise: Longer and more intense workouts can lead to more issues.
Temperature and Humidity: Cold, dry air can worsen symptoms; warm, humid air can help.
Mechanisms of EIB
Hyperosmolar Environment: When you breathe fast and lose water and heat, it can lead to bronchoconstriction due to histamine and leukotriene release.
Nasal vs. Mouth Breathing: Breathing through the nose can help warm and moisten the air, reducing triggers.
Strategies to Mitigate EIB
Exercise Training: Helps lower breathing rates during exercise, which may decrease EIB frequency.
Warm-up: Warming up before exercise can boost epinephrine levels, preventing symptoms.
Introduction to the Cardiovascular System
In this section, we will focus on how the heart and blood vessels work together for fitness, specifically looking at:
Key Concepts:
Understanding heart rate, stroke volume, and oxygen difference during exercise.
Heart Rate: How fast the heart beats.
Stroke Volume: The amount of blood pumped out with each heartbeat.
A-V Oxygen Difference: The difference in oxygen content between arteries and veins.
Structural Differences in the Heart
Wall Thickness:
Right Ventricle: Has a thin wall, pumping blood to the lungs under lower pressure.
Left Ventricle: Has a thick wall for pumping blood to the rest of the body under high pressure.
Afterload:
The pressure the heart works against.
Right heart: Low afterload (~25 mmHg in pulmonary circulation).
Left heart: High afterload (~100 mmHg in systemic circulation).
Cardiac Hypertrophy
Adaptation to workload; the heart wall thickens with increased demands.
Types of Hypertrophy:
Concentric Hypertrophy: Occurs due to high blood pressure (hypertension).
Eccentric Hypertrophy: Occurs from high blood volume, often from endurance training.
Cardiac Cellular Structure
Intercalated Discs: Special connections between heart cells that help synchronize their contractions.
Heart cells change size and shape based on how hard they work.
Unique features:
Gap Junctions: Allow rapid electrical propagation between cells.
Single Nucleus: Unlike multi-nucleated skeletal muscle cells
Blood Flow in the Heart
Occlusion and Ischemia:
Occlusion: Blockage in heart vessels from plaque buildup.
Ischemia Consequences: Less blood flow can cause chest pain (angina) or heart attacks.
Cardiac Phases
Systole vs. Diastole:
Blood flow to coronary vessels mainly happens during diastole when the heart is relaxed, not contracting.
Share
You said:
We were introducing asthma, and that's our last topic for the respiratory system. It's a good topic, though. It applies to a lot of people. Then we'll start into our last section, which is the cardiovascular system. You're going to learn about granulation today and FEV1 performance in this obstructive disease that we call asthma. So we had introduced a few concepts: risk factors, sensitivity to a particular immunoglobulin E which triggers the response. There are genetic predispositions, of course, for asthma, and other risk factors exist, including temperature of the air, exposure to smoke, dust, infections, etc. The genetic influences are shown here. We're going to talk about different cell types today, including goblet cells that secrete substances, mast cells that also secrete substances and undergo a process called degranulation. We'll talk about leukocytes and how they play a role in inflammation. What we're discussing here is the difference in the airways between a normal, healthy person and an asthmatic person. You can see the airway is nicely wide open. This is the smooth muscle out here. This is the layer of cells. This is the airway. In an asthmatic individual, we have a lot of mucus plugs, inflammation, and bronchoconstriction taking place. So we've got to deal with a couple of things: one is the inflammation, and the other is the bronchoconstriction, which narrows the airway and makes it difficult for these upper airways. This is not small airway disease; this is upper airway conductive airways, bronchi, and upper bronchioles that become constricted. Now, how does exercise influence this? That's what we're going to talk about, of course, as well. All right. So let's get into the pathway of these different cell types and how they interact in response to a trigger like pollen or dust or something like that. Then I'll tell you how exercise affects the pathway. Individuals with asthma are sensitive to triggers that activate this pathway because they have a lot of this IgE. IgE is an immunoglobulin E secreted by a particular cell type, and it binds to this cell, which is the mast cell that I just pointed out on the previous page. The IgE acts as a receptor for a variety of triggers, like pollen, dust mites, and perhaps animal dander, that sort of thing. When activated, it causes a process called exocytosis, but in this particular context, it's called degranulation because these mast cells, if you look at them under the microscope, have these granules. They look different under the microscope, easy to see. Degranulation simply means the emptying of those granules into the extracellular fluid. So it's called degranulation because we empty out, through exocytosis, this molecule called histamine. Histamine circulates to two types of cells: one is bronchial smooth muscle, and you can imagine where I'm going with that. We're going to get contraction of the smooth muscle which surrounds the airway, and that's going to constrict the airway. The second thing that it's going to do is bind to leukocytes, which are white blood cells in the area, and that's going to promote inflammation. One of the steps involved here is the binding of this allergen to the receptor IgE acting as a receptor. It causes the movement of the granule to the membrane, fusion, and the typical process of exocytosis. We know exocytosis takes place in many cell types and through common mechanisms. This is what's happening here. Histamine is released and will go to H1 receptors. H1 is the histamine one isoform receptor for histamine. On bronchial smooth muscle cells, that activates a biochemical pathway, details of which we won't go into, but the end result is constriction. Histamine will also bind to H1 receptors on leukocytes, and in that process, activate an enzyme called phospholipase A2. You can imagine what that is; that's an enzyme, of course, isoform A2. It's going to break down a phospholipid, taking the special fatty acids off the phospholipid. Those special fatty acids are called arachidonic acid. Arachidonic acid is a breakdown product of phospholipase A2 activation. When histamine binds to an H1 receptor, arachidonic acid is converted in that cell to leukotrienes. Just so you remember, leukotrienes are pro-inflammatory molecules. They cause inflammation, swelling, and secretion of substances from those goblet cells, promoting inflammation. So how do we attack this issue? Well, it turns out that when epinephrine or catecholamine, one of our favorite catecholamines, antagonizes this. Epinephrine binds to beta receptors in these cells. Epinephrine binds to beta-2 receptors in the cell. The one we're going to hear about in a day or two. Beta-1 receptors are in the heart; beta-2 receptors are in the liver, muscle, and mast cells. That's the different isoform. It activates adenylate cyclase, converting ATP to cyclic AMP, like we learned in glycogen breakdown. We learned about that same thing happening here. It's the same receptor; it's going to activate the same pathway, except the consequence is different. The difference is that after the activation of cyclic AMP, we have step after step, and it inhibits degranulation. Inhibiting degranulation means no histamine release, and so that is preventative against the bronchoconstriction and the inflammatory response here. That's pretty good. Epinephrine also promotes, when it binds to beta-2 receptors in bronchial smooth muscle, the relaxation of that smooth muscle and the dilation of the airway. So that is also good, counteracting what histamine does. You can imagine where some of these steps might lead us. We're going to talk about some drugs that impact this pathway, and epinephrine, you know, goes up with exercise. So that sounds good; it might be helpful for us as we discuss exercise-induced bronchoconstriction. What are some drugs that might inhibit this pathway? This has long been studied; this is not new material. You can look this up very easily and find the therapies for bronchoconstriction. Here are some of the most popular drugs. We have to inhibit this inflammation, and we have to promote bronchodilation, or we have to inhibit this degranulation, which started the whole process off. A couple of drugs do that. Prednisone, a well-known steroid and anti-inflammatory drug, is an inhibitor of phospholipase A2. This acts on the genome to inhibit the transcription of phospholipase A2. This is not a real short-term solution; you need to take prednisone, usually as a puffer. That puffer is taken for weeks to inhibit the transcription of phospholipase A2 to prevent the pro-inflammatory synthesis of these pro-inflammatory molecules. Okay, puffer prednisone. You know, puffer long-term treatment. That's what I mean. Weeks of treatment, short-term, of course, is very commonly known. You take a puffer, and in the puffer, we have a beta-2 receptor agonist, not an antagonist. Now, remember, we talked about beta blockers at one time. That's an antagonist. Obviously, a blocker antagonizes the action of the normal hormone. This is an agonist, like epinephrine. Pharmaceutical companies make these drugs so that they last longer in circulation, not having a short half-life. That's what this one is, like salbutamol. Salbutamol is also called Ventolin. You take it in a puffer as well, a different puffer. You're going to get that in the airway, and it's going to bind to the beta-2 receptor and promote this pathway. It's going to last longer than epinephrine would if you were counting on epinephrine-induced action. write nice and neat notes make it organized, dont miss anything from the lecture/transcript and use simple words so its easy to understand
ChatGPT said:
ChatGPT
Asthma: Overview and Pathophysiology
Definition and Relevance
Asthma is a chronic obstructive respiratory disease affecting the airways.
It involves inflammation, bronchoconstriction, and mucus plug formation, primarily affecting the upper airways (bronchi and upper bronchioles).
Triggers include allergens like pollen, dust mites, animal dander, smoke, infections, and cold air.
Key Features of Asthma
In asthmatic airways:
Inflammation: Swelling of the airway lining.
Bronchoconstriction: Tightening of the smooth muscles around the airway.
Mucus plugs: Excessive secretion blocks airflow.
Immune Response in Asthma
Trigger Pathway
IgE Sensitivity:
Asthmatics have higher levels of immunoglobulin E (IgE).
IgE acts as a receptor for allergens like pollen or dust.
Mast Cell Degranulation:
Allergens bind to IgE on mast cells, triggering degranulation (release of granules).
Histamine, a key granule content, is released into the extracellular fluid.
Effects of Histamine
Bronchoconstriction:
Histamine binds to H1 receptors on bronchial smooth muscle, causing contraction and airway narrowing.
Inflammation:
Histamine binds to H1 receptors on leukocytes.
Activates phospholipase A2 enzyme, which breaks down phospholipids into arachidonic acid.
Arachidonic acid is converted into leukotrienes, pro-inflammatory molecules that:
Increase swelling.
Stimulate goblet cells to secrete more mucus.
Role of Epinephrine and Beta-2 Receptors
Epinephrine (a catecholamine) antagonizes histamine effects:
Inhibits Degranulation:
Binds to beta-2 receptors on mast cells.
Activates adenylate cyclase, converting ATP to cyclic AMP.
Cyclic AMP prevents degranulation, reducing histamine release.
Promotes Bronchodilation:
Binds to beta-2 receptors on bronchial smooth muscle, causing relaxation and airway dilation.
Drugs for Asthma Management
Goals of Treatment
Inhibit inflammation.
Promote bronchodilation.
Inhibit degranulation.
Types of Asthma Medications
Long-Term Anti-Inflammatory Drugs
Prednisone:
A steroid taken as a puffer for weeks.
Inhibits transcription of phospholipase A2, reducing leukotriene production.
Used for sustained inflammation control.
Short-Term Bronchodilators
Salbutamol (Ventolin):
A beta-2 receptor agonist, similar to epinephrine but with a longer half-life.
Delivered via puffer for immediate relief of bronchoconstriction.
Promotes smooth muscle relaxation and airway dilation.
Exercise and Asthma
Epinephrine Release:
Exercise increases epinephrine levels, which may help reduce asthma symptoms by:
Inhibiting mast cell degranulation.
Promoting airway dilation.
Exercise-Induced Bronchoconstriction (EIB):
Some individuals experience airway narrowing during or after exercise, requiring additional management.
Key Takeaways
Asthma involves a complex interaction between immune cells, inflammatory mediators, and airway smooth muscle.
Management focuses on controlling inflammation, preventing bronchoconstriction, and providing symptomatic relief using medications.
Exercise can both trigger and alleviate symptoms depending on the individual's response.